MedPath

Gostigmine

Brand Name: Gostigmine

Generic Name: Neostigmine (as methylsulfate)

Active
Registration Number

DRP-6823-02

Dosage Form

Solution for Injection (I.M./I.V./S.C.)

Issuance Date

September 14, 2023

Expiry Date

September 1, 2028

Product Information

Philippine FDA product specifications and classification details

Product Specifications

Dosage Strength500 mcg/mL
PackagingUSP Type I Clear Glass Ampoule x 1 mL (Box of 6’s)

Classification

C
Classification
Prescription Drug (Rx)
P
Pharmacologic
CHOLINESTERASE INHIBITOR
A
Application
Renewal
Philippine FDA Classification

Active Ingredients (1)

Complete list of active ingredients in this pharmaceutical product.

Neostigmine (as methylsulfate)Active
Monograph: neostigmine (as methylsulfate)

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.

MedPath - Medical Intelligence Platform